Data Descriptor: Pharmacological and genomic profiling of neurofibromatosis type 1 plexiform neurofibroma-derived schwann cells

Marc Ferrer, Sara J.C. Gosline, Marigo Stathis, Xiaohu Zhang, Xindi Guo, Rajarshi Guha, Dannielle A. Ryman, Margaret R. Wallace, Laura Kasch-Semenza, Haiping Hao, Roxann Ingersoll, David Mohr, Craig Thomas, Sharad Verma, Justin Guinney, Jaishri Blakeley

Research output: Contribution to journalArticle

Abstract

Neurofibromatosis type I (NF1) is an autosomal dominant genetic condition characterized by peripheral nervous system tumors (PNSTs), including plexiform neurofibromas (pNFs) that cause nerve dysfunction, deformity, pain damage to adjacent structures, and can undergo malignant transformation. There are no effective therapies to prevent or treat pNFs. Drug discovery efforts are slowed by the 'benign' nature of the Schwann cells that are the progenitor cells of pNF. In this work we characterize a set of pNF-derived cell lines at the genomic level (via SNP Arrays, RNAseq, and Whole Exome- Sequencing), and carry out dose response-based quantitative high-throughput screening (qHTS) with a collection of 1,912 oncology-focused compounds in a 1536-well microplate cell proliferation assays. Through the characterization and screening of NF1(-/-), NF1(+/+) and NF1(+/-) Schwann cell lines, this resource introduces novel therapeutic avenues for the development for NF1 associated pNF as well as all solid tumors with NF1 somatic mutations. The integrated data sets are openly available for further analysis at http://www.synapse.org/pnf Cell Culture.

Original languageEnglish (US)
Article number180106
JournalScientific data
Volume5
DOIs
StatePublished - Jun 12 2018

Fingerprint

deformity
Profiling
proliferation
Descriptors
Genomics
pain
damages
Cells
drug
cause
Tumors
Cell
Screening
resources
Tumor
Oncology
Cell proliferation
Neurology
High-throughput Screening
Cell culture

ASJC Scopus subject areas

  • Statistics and Probability
  • Information Systems
  • Education
  • Computer Science Applications
  • Statistics, Probability and Uncertainty
  • Library and Information Sciences

Cite this

Data Descriptor : Pharmacological and genomic profiling of neurofibromatosis type 1 plexiform neurofibroma-derived schwann cells. / Ferrer, Marc; Gosline, Sara J.C.; Stathis, Marigo; Zhang, Xiaohu; Guo, Xindi; Guha, Rajarshi; Ryman, Dannielle A.; Wallace, Margaret R.; Kasch-Semenza, Laura; Hao, Haiping; Ingersoll, Roxann; Mohr, David; Thomas, Craig; Verma, Sharad; Guinney, Justin; Blakeley, Jaishri.

In: Scientific data, Vol. 5, 180106, 12.06.2018.

Research output: Contribution to journalArticle

Ferrer, M, Gosline, SJC, Stathis, M, Zhang, X, Guo, X, Guha, R, Ryman, DA, Wallace, MR, Kasch-Semenza, L, Hao, H, Ingersoll, R, Mohr, D, Thomas, C, Verma, S, Guinney, J & Blakeley, J 2018, 'Data Descriptor: Pharmacological and genomic profiling of neurofibromatosis type 1 plexiform neurofibroma-derived schwann cells', Scientific data, vol. 5, 180106. https://doi.org/10.1038/sdata.2018.106
Ferrer, Marc ; Gosline, Sara J.C. ; Stathis, Marigo ; Zhang, Xiaohu ; Guo, Xindi ; Guha, Rajarshi ; Ryman, Dannielle A. ; Wallace, Margaret R. ; Kasch-Semenza, Laura ; Hao, Haiping ; Ingersoll, Roxann ; Mohr, David ; Thomas, Craig ; Verma, Sharad ; Guinney, Justin ; Blakeley, Jaishri. / Data Descriptor : Pharmacological and genomic profiling of neurofibromatosis type 1 plexiform neurofibroma-derived schwann cells. In: Scientific data. 2018 ; Vol. 5.
@article{e308aff9d6b74e13845a15986aaee1ba,
title = "Data Descriptor: Pharmacological and genomic profiling of neurofibromatosis type 1 plexiform neurofibroma-derived schwann cells",
abstract = "Neurofibromatosis type I (NF1) is an autosomal dominant genetic condition characterized by peripheral nervous system tumors (PNSTs), including plexiform neurofibromas (pNFs) that cause nerve dysfunction, deformity, pain damage to adjacent structures, and can undergo malignant transformation. There are no effective therapies to prevent or treat pNFs. Drug discovery efforts are slowed by the 'benign' nature of the Schwann cells that are the progenitor cells of pNF. In this work we characterize a set of pNF-derived cell lines at the genomic level (via SNP Arrays, RNAseq, and Whole Exome- Sequencing), and carry out dose response-based quantitative high-throughput screening (qHTS) with a collection of 1,912 oncology-focused compounds in a 1536-well microplate cell proliferation assays. Through the characterization and screening of NF1(-/-), NF1(+/+) and NF1(+/-) Schwann cell lines, this resource introduces novel therapeutic avenues for the development for NF1 associated pNF as well as all solid tumors with NF1 somatic mutations. The integrated data sets are openly available for further analysis at http://www.synapse.org/pnf Cell Culture.",
author = "Marc Ferrer and Gosline, {Sara J.C.} and Marigo Stathis and Xiaohu Zhang and Xindi Guo and Rajarshi Guha and Ryman, {Dannielle A.} and Wallace, {Margaret R.} and Laura Kasch-Semenza and Haiping Hao and Roxann Ingersoll and David Mohr and Craig Thomas and Sharad Verma and Justin Guinney and Jaishri Blakeley",
year = "2018",
month = "6",
day = "12",
doi = "10.1038/sdata.2018.106",
language = "English (US)",
volume = "5",
journal = "Scientific data",
issn = "2052-4463",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Data Descriptor

T2 - Pharmacological and genomic profiling of neurofibromatosis type 1 plexiform neurofibroma-derived schwann cells

AU - Ferrer, Marc

AU - Gosline, Sara J.C.

AU - Stathis, Marigo

AU - Zhang, Xiaohu

AU - Guo, Xindi

AU - Guha, Rajarshi

AU - Ryman, Dannielle A.

AU - Wallace, Margaret R.

AU - Kasch-Semenza, Laura

AU - Hao, Haiping

AU - Ingersoll, Roxann

AU - Mohr, David

AU - Thomas, Craig

AU - Verma, Sharad

AU - Guinney, Justin

AU - Blakeley, Jaishri

PY - 2018/6/12

Y1 - 2018/6/12

N2 - Neurofibromatosis type I (NF1) is an autosomal dominant genetic condition characterized by peripheral nervous system tumors (PNSTs), including plexiform neurofibromas (pNFs) that cause nerve dysfunction, deformity, pain damage to adjacent structures, and can undergo malignant transformation. There are no effective therapies to prevent or treat pNFs. Drug discovery efforts are slowed by the 'benign' nature of the Schwann cells that are the progenitor cells of pNF. In this work we characterize a set of pNF-derived cell lines at the genomic level (via SNP Arrays, RNAseq, and Whole Exome- Sequencing), and carry out dose response-based quantitative high-throughput screening (qHTS) with a collection of 1,912 oncology-focused compounds in a 1536-well microplate cell proliferation assays. Through the characterization and screening of NF1(-/-), NF1(+/+) and NF1(+/-) Schwann cell lines, this resource introduces novel therapeutic avenues for the development for NF1 associated pNF as well as all solid tumors with NF1 somatic mutations. The integrated data sets are openly available for further analysis at http://www.synapse.org/pnf Cell Culture.

AB - Neurofibromatosis type I (NF1) is an autosomal dominant genetic condition characterized by peripheral nervous system tumors (PNSTs), including plexiform neurofibromas (pNFs) that cause nerve dysfunction, deformity, pain damage to adjacent structures, and can undergo malignant transformation. There are no effective therapies to prevent or treat pNFs. Drug discovery efforts are slowed by the 'benign' nature of the Schwann cells that are the progenitor cells of pNF. In this work we characterize a set of pNF-derived cell lines at the genomic level (via SNP Arrays, RNAseq, and Whole Exome- Sequencing), and carry out dose response-based quantitative high-throughput screening (qHTS) with a collection of 1,912 oncology-focused compounds in a 1536-well microplate cell proliferation assays. Through the characterization and screening of NF1(-/-), NF1(+/+) and NF1(+/-) Schwann cell lines, this resource introduces novel therapeutic avenues for the development for NF1 associated pNF as well as all solid tumors with NF1 somatic mutations. The integrated data sets are openly available for further analysis at http://www.synapse.org/pnf Cell Culture.

UR - http://www.scopus.com/inward/record.url?scp=85048416367&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048416367&partnerID=8YFLogxK

U2 - 10.1038/sdata.2018.106

DO - 10.1038/sdata.2018.106

M3 - Article

C2 - 29893754

AN - SCOPUS:85048416367

VL - 5

JO - Scientific data

JF - Scientific data

SN - 2052-4463

M1 - 180106

ER -